E. Liu

Selectively Targeting Tumor Hypoxia With the Hypoxia-Activated Prodrug CP-506

P. Lambin, L. Dubois, A. Jochems, 2021, Molecular Cancer Therapeutics.

Selectively Targeting Tumor Hypoxia With the Hypoxia-Activated Prodrug CP-506

P. Lambin, L. Dubois, A. Jochems, 2021, Molecular Cancer Therapeutics.

Gene array of VHL mutation and hypoxia shows novel hypoxia-induced genes and that cyclin D1 is a VHL target gene

C. Sotiriou, A. Harris, C. Wykoff, 2004, British Journal of Cancer.

Menthol: An underestimated anticancer agent

Wei Liu, Huafeng Pan, Jinhao Zeng, 2023, Frontiers in Pharmacology.

Tissue Pharmacokinetic Properties and Bystander Potential of Hypoxia-Activated Prodrug CP-506 by Agent-Based Modelling

J. Smaill, K. Hicks, A. Patterson, 2022, Frontiers in Pharmacology.